• レポートコード:D0804-02063 • 出版社/出版日:GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態:英語、PDF、135ページ • 納品方法:Eメール • 産業分類:医療機器・医療消耗品 |
Single User | ¥504,600 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥756,900 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、がんアブレーション装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。がんアブレーション装置の種類別市場規模(冷凍アブレーション、高強度集束超音波(HIFU)、レーザー間質温熱療法(LiTT)、マイクロ波アブレーション(MWA)、高周波アブレーション(RFA)、不可逆エレクトロポレーション(Ire)、非熱アブレーション)、用途別市場規模(脳がん、ブラウン、大腸がん、腎臓がん、肝臓がん、肺がん、膵臓がん、前立腺がん)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Alfresa Pharma Corp.、ECO Medical、Biomedical S.r.l.、AngioDynamics, Inc.、Chongqing Haifu Medical Technology Co., Ltd、BTG plc (Galil Medical Ltd./Perseon Medical)、HS Hospital Service S.p.A.、CSA Medical, Inc.、Boston Scientific Corporation、EDAP TMS S.A.、MedWaves, Inc.、IceCure Medical, Inc.、MedLink Technologies LLC、Johnson & Johnson (Ethicon, Inc.)、Kang-Yu Medical Co., Ltd. ・地域別グローバル市場分析 2015年-2020年 ・がんアブレーション装置の北米市場(アメリカ、カナダ、メキシコ) ・がんアブレーション装置のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・がんアブレーション装置のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・がんアブレーション装置の南米市場(ブラジル、アルゼンチン) ・がんアブレーション装置の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:冷凍アブレーション、高強度集束超音波(HIFU)、レーザー間質温熱療法(LiTT)、マイクロ波アブレーション(MWA)、高周波アブレーション(RFA)、不可逆エレクトロポレーション(Ire)、非熱アブレーション ・用途別分析:脳がん、ブラウン、大腸がん、腎臓がん、肝臓がん、肺がん、膵臓がん、前立腺がん ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Cancer Ablation Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Cancer Ablation Devices sales will be xx in 2020 from Cancer Ablation Devices million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cancer Ablation Devices market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Cancer Ablation Devices industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cancer Ablation Devices and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Cancer Ablation Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Ablation Devices market has been segmented into
Cryoablation
High-Intensity Focused Ultrasound (HIFU)
Laser Interstitial Thermal Therapy (LiTT)
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Irreversible Electroporation (Ire)
Non-Thermal Ablation
By Application, Cancer Ablation Devices has been segmented into:
Brain Cancer
Brown
Colorectal Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Ablation Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Ablation Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Ablation Devices market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Ablation Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Ablation Devices Market Share Analysis
Cancer Ablation Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Ablation Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Ablation Devices sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Ablation Devices are:
Alfresa Pharma Corp.
ECO Medical
Biomedical S.r.l.
AngioDynamics, Inc.
Chongqing Haifu Medical Technology Co., Ltd
BTG plc (Galil Medical Ltd./Perseon Medical)
HS Hospital Service S.p.A.
CSA Medical, Inc.
Boston Scientific Corporation
EDAP TMS S.A.
MedWaves, Inc.
IceCure Medical, Inc.
MedLink Technologies LLC
Johnson & Johnson (Ethicon, Inc.)
Kang-Yu Medical Co., Ltd.
Among other players domestic and global, Cancer Ablation Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Ablation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Ablation Devices, with price, sales, revenue and global market share of Cancer Ablation Devices in 2018 and 2019.
Chapter 3, the Cancer Ablation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Ablation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cancer Ablation Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cancer Ablation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cancer Ablation Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Ablation Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cryoablation
1.2.3 High-Intensity Focused Ultrasound (HIFU)
1.2.4 Laser Interstitial Thermal Therapy (LiTT)
1.2.5 Microwave Ablation (MWA)
1.2.6 Radiofrequency Ablation (RFA)
1.2.7 Irreversible Electroporation (Ire)
1.2.8 Non-Thermal Ablation
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Ablation Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Brain Cancer
1.3.3 Brown
1.3.4 Colorectal Cancer
1.3.5 Kidney Cancer
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Pancreatic Cancer
1.3.9 Prostate Cancer
1.4 Overview of Global Cancer Ablation Devices Market
1.4.1 Global Cancer Ablation Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Cancer Ablation Devices Industry Impact
1.6.1 COVID-19 Potential Implications for the Cancer Ablation Devices
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cancer Ablation Devices
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Alfresa Pharma Corp.
2.1.1 Alfresa Pharma Corp. Details
2.1.2 Alfresa Pharma Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alfresa Pharma Corp. SWOT Analysis
2.1.4 Alfresa Pharma Corp. Product and Services
2.1.5 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ECO Medical
2.2.1 ECO Medical Details
2.2.2 ECO Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ECO Medical SWOT Analysis
2.2.4 ECO Medical Product and Services
2.2.5 ECO Medical Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biomedical S.r.l.
2.3.1 Biomedical S.r.l. Details
2.3.2 Biomedical S.r.l. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biomedical S.r.l. SWOT Analysis
2.3.4 Biomedical S.r.l. Product and Services
2.3.5 Biomedical S.r.l. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AngioDynamics, Inc.
2.4.1 AngioDynamics, Inc. Details
2.4.2 AngioDynamics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AngioDynamics, Inc. SWOT Analysis
2.4.4 AngioDynamics, Inc. Product and Services
2.4.5 AngioDynamics, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Chongqing Haifu Medical Technology Co., Ltd
2.5.1 Chongqing Haifu Medical Technology Co., Ltd Details
2.5.2 Chongqing Haifu Medical Technology Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Chongqing Haifu Medical Technology Co., Ltd SWOT Analysis
2.5.4 Chongqing Haifu Medical Technology Co., Ltd Product and Services
2.5.5 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BTG plc (Galil Medical Ltd./Perseon Medical)
2.6.1 BTG plc (Galil Medical Ltd./Perseon Medical) Details
2.6.2 BTG plc (Galil Medical Ltd./Perseon Medical) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BTG plc (Galil Medical Ltd./Perseon Medical) SWOT Analysis
2.6.4 BTG plc (Galil Medical Ltd./Perseon Medical) Product and Services
2.6.5 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 HS Hospital Service S.p.A.
2.7.1 HS Hospital Service S.p.A. Details
2.7.2 HS Hospital Service S.p.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 HS Hospital Service S.p.A. SWOT Analysis
2.7.4 HS Hospital Service S.p.A. Product and Services
2.7.5 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CSA Medical, Inc.
2.8.1 CSA Medical, Inc. Details
2.8.2 CSA Medical, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CSA Medical, Inc. SWOT Analysis
2.8.4 CSA Medical, Inc. Product and Services
2.8.5 CSA Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boston Scientific Corporation
2.9.1 Boston Scientific Corporation Details
2.9.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boston Scientific Corporation SWOT Analysis
2.9.4 Boston Scientific Corporation Product and Services
2.9.5 Boston Scientific Corporation Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 EDAP TMS S.A.
2.10.1 EDAP TMS S.A. Details
2.10.2 EDAP TMS S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 EDAP TMS S.A. SWOT Analysis
2.10.4 EDAP TMS S.A. Product and Services
2.10.5 EDAP TMS S.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 MedWaves, Inc.
2.11.1 MedWaves, Inc. Details
2.11.2 MedWaves, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 MedWaves, Inc. SWOT Analysis
2.11.4 MedWaves, Inc. Product and Services
2.11.5 MedWaves, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 IceCure Medical, Inc.
2.12.1 IceCure Medical, Inc. Details
2.12.2 IceCure Medical, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 IceCure Medical, Inc. SWOT Analysis
2.12.4 IceCure Medical, Inc. Product and Services
2.12.5 IceCure Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 MedLink Technologies LLC
2.13.1 MedLink Technologies LLC Details
2.13.2 MedLink Technologies LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MedLink Technologies LLC SWOT Analysis
2.13.4 MedLink Technologies LLC Product and Services
2.13.5 MedLink Technologies LLC Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Johnson & Johnson (Ethicon, Inc.)
2.14.1 Johnson & Johnson (Ethicon, Inc.) Details
2.14.2 Johnson & Johnson (Ethicon, Inc.) Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Johnson & Johnson (Ethicon, Inc.) SWOT Analysis
2.14.4 Johnson & Johnson (Ethicon, Inc.) Product and Services
2.14.5 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Kang-Yu Medical Co., Ltd.
2.15.1 Kang-Yu Medical Co., Ltd. Details
2.15.2 Kang-Yu Medical Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Kang-Yu Medical Co., Ltd. SWOT Analysis
2.15.4 Kang-Yu Medical Co., Ltd. Product and Services
2.15.5 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cancer Ablation Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cancer Ablation Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Ablation Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Cancer Ablation Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cancer Ablation Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Ablation Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cancer Ablation Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Cancer Ablation Devices Sales and Growth Rate (2015-2020)
4.3 Europe Cancer Ablation Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Ablation Devices Sales and Growth Rate (2015-2020)
4.5 South America Cancer Ablation Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cancer Ablation Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cancer Ablation Devices Sales, Revenue and Market Share by Country
5.1.1 North America Cancer Ablation Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Cancer Ablation Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Cancer Ablation Devices Sales and Growth Rate (2015-2020)
5.3 Canada Cancer Ablation Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Cancer Ablation Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cancer Ablation Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Cancer Ablation Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cancer Ablation Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Cancer Ablation Devices Sales and Growth Rate (2015-2020)
6.3 UK Cancer Ablation Devices Sales and Growth Rate (2015-2020)
6.4 France Cancer Ablation Devices Sales and Growth Rate (2015-2020)
6.5 Russia Cancer Ablation Devices Sales and Growth Rate (2015-2020)
6.6 Italy Cancer Ablation Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cancer Ablation Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cancer Ablation Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cancer Ablation Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Cancer Ablation Devices Sales and Growth Rate (2015-2020)
7.3 Japan Cancer Ablation Devices Sales and Growth Rate (2015-2020)
7.4 Korea Cancer Ablation Devices Sales and Growth Rate (2015-2020)
7.5 India Cancer Ablation Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Ablation Devices Sales and Growth Rate (2015-2020)
7.7 Australia Cancer Ablation Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cancer Ablation Devices Sales, Revenue and Market Share by Country
8.1.1 South America Cancer Ablation Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Cancer Ablation Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cancer Ablation Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Cancer Ablation Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cancer Ablation Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cancer Ablation Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cancer Ablation Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cancer Ablation Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Cancer Ablation Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer Ablation Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Cancer Ablation Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cancer Ablation Devices Sales and Market Share by Type (2015-2020)
10.2 Global Cancer Ablation Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Cancer Ablation Devices Price by Type (2015-2020)
11 Global Cancer Ablation Devices Market Segment by Application
11.1 Global Cancer Ablation Devices Sales Market Share by Application (2015-2020)
11.2 Global Cancer Ablation Devices Revenue Market Share by Application (2015-2020)
11.3 Global Cancer Ablation Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cancer Ablation Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Cancer Ablation Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Cancer Ablation Devices Market Forecast (2021-2025)
12.2.2 Europe Cancer Ablation Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cancer Ablation Devices Market Forecast (2021-2025)
12.2.4 South America Cancer Ablation Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cancer Ablation Devices Market Forecast (2021-2025)
12.3 Cancer Ablation Devices Market Forecast by Type (2021-2025)
12.3.1 Global Cancer Ablation Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Cancer Ablation Devices Market Share Forecast by Type (2021-2025)
12.4 Cancer Ablation Devices Market Forecast by Application (2021-2025)
12.4.1 Global Cancer Ablation Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Cancer Ablation Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cancer Ablation Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Ablation Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Ablation Devices Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Cancer Ablation Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Alfresa Pharma Corp. Basic Information, Manufacturing Base and Competitors
Table 9. Alfresa Pharma Corp. Cancer Ablation Devices Major Business
Table 10. Alfresa Pharma Corp. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 11. Alfresa Pharma Corp. SWOT Analysis
Table 12. Alfresa Pharma Corp. Cancer Ablation Devices Product and Services
Table 13. Alfresa Pharma Corp. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. ECO Medical Basic Information, Manufacturing Base and Competitors
Table 15. ECO Medical Cancer Ablation Devices Major Business
Table 16. ECO Medical Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 17. ECO Medical SWOT Analysis
Table 18. ECO Medical Cancer Ablation Devices Product and Services
Table 19. ECO Medical Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Biomedical S.r.l. Basic Information, Manufacturing Base and Competitors
Table 21. Biomedical S.r.l. Cancer Ablation Devices Major Business
Table 22. Biomedical S.r.l. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 23. Biomedical S.r.l. SWOT Analysis
Table 24. Biomedical S.r.l. Cancer Ablation Devices Product and Services
Table 25. Biomedical S.r.l. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. AngioDynamics, Inc. Basic Information, Manufacturing Base and Competitors
Table 27. AngioDynamics, Inc. Cancer Ablation Devices Major Business
Table 28. AngioDynamics, Inc. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 29. AngioDynamics, Inc. SWOT Analysis
Table 30. AngioDynamics, Inc. Cancer Ablation Devices Product and Services
Table 31. AngioDynamics, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Chongqing Haifu Medical Technology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 33. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Major Business
Table 34. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 35. Chongqing Haifu Medical Technology Co., Ltd SWOT Analysis
Table 36. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product and Services
Table 37. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. BTG plc (Galil Medical Ltd./Perseon Medical) Basic Information, Manufacturing Base and Competitors
Table 39. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Major Business
Table 40. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 41. BTG plc (Galil Medical Ltd./Perseon Medical) SWOT Analysis
Table 42. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product and Services
Table 43. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. HS Hospital Service S.p.A. Basic Information, Manufacturing Base and Competitors
Table 45. HS Hospital Service S.p.A. Cancer Ablation Devices Major Business
Table 46. HS Hospital Service S.p.A. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 47. HS Hospital Service S.p.A. SWOT Analysis
Table 48. HS Hospital Service S.p.A. Cancer Ablation Devices Product and Services
Table 49. HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. CSA Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 51. CSA Medical, Inc. Cancer Ablation Devices Major Business
Table 52. CSA Medical, Inc. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 53. CSA Medical, Inc. SWOT Analysis
Table 54. CSA Medical, Inc. Cancer Ablation Devices Product and Services
Table 55. CSA Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 57. Boston Scientific Corporation Cancer Ablation Devices Major Business
Table 58. Boston Scientific Corporation Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 59. Boston Scientific Corporation SWOT Analysis
Table 60. Boston Scientific Corporation Cancer Ablation Devices Product and Services
Table 61. Boston Scientific Corporation Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. EDAP TMS S.A. Basic Information, Manufacturing Base and Competitors
Table 63. EDAP TMS S.A. Cancer Ablation Devices Major Business
Table 64. EDAP TMS S.A. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 65. EDAP TMS S.A. SWOT Analysis
Table 66. EDAP TMS S.A. Cancer Ablation Devices Product and Services
Table 67. EDAP TMS S.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. MedWaves, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. MedWaves, Inc. Cancer Ablation Devices Major Business
Table 70. MedWaves, Inc. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 71. MedWaves, Inc. SWOT Analysis
Table 72. MedWaves, Inc. Cancer Ablation Devices Product and Services
Table 73. MedWaves, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. IceCure Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 75. IceCure Medical, Inc. Cancer Ablation Devices Major Business
Table 76. IceCure Medical, Inc. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 77. IceCure Medical, Inc. SWOT Analysis
Table 78. IceCure Medical, Inc. Cancer Ablation Devices Product and Services
Table 79. IceCure Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. MedLink Technologies LLC Basic Information, Manufacturing Base and Competitors
Table 81. MedLink Technologies LLC Cancer Ablation Devices Major Business
Table 82. MedLink Technologies LLC Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 83. MedLink Technologies LLC SWOT Analysis
Table 84. MedLink Technologies LLC Cancer Ablation Devices Product and Services
Table 85. MedLink Technologies LLC Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Johnson & Johnson (Ethicon, Inc.) Basic Information, Manufacturing Base and Competitors
Table 87. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Major Business
Table 88. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 89. Johnson & Johnson (Ethicon, Inc.) SWOT Analysis
Table 90. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product and Services
Table 91. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Kang-Yu Medical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 93. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Major Business
Table 94. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Total Revenue (USD Million) (2018-2019)
Table 95. Kang-Yu Medical Co., Ltd. SWOT Analysis
Table 96. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product and Services
Table 97. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Global Cancer Ablation Devices Sales by Manufacturer (2018-2019) (K Units)
Table 99. Global Cancer Ablation Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 100. Global Cancer Ablation Devices Sales by Regions (2015-2020) (K Units)
Table 101. Global Cancer Ablation Devices Sales Market Share by Regions (2015-2020)
Table 102. Global Cancer Ablation Devices Revenue by Regions (2015-2020) (USD Million)
Table 103. North America Cancer Ablation Devices Sales by Countries (2015-2020) (K Units)
Table 104. North America Cancer Ablation Devices Sales Market Share by Countries (2015-2020)
Table 105. North America Cancer Ablation Devices Revenue by Countries (2015-2020) (USD Million)
Table 106. North America Cancer Ablation Devices Revenue Market Share by Countries (2015-2020)
Table 107. Europe Cancer Ablation Devices Sales by Countries (2015-2020) (K Units)
Table 108. Europe Cancer Ablation Devices Sales Market Share by Countries (2015-2020)
Table 109. Europe Cancer Ablation Devices Revenue by Countries (2015-2020) (USD Million)
Table 110. Asia-Pacific Cancer Ablation Devices Sales by Regions (2015-2020) (K Units)
Table 111. Asia-Pacific Cancer Ablation Devices Sales Market Share by Regions (2015-2020)
Table 112. Asia-Pacific Cancer Ablation Devices Revenue by Regions (2015-2020) (USD Million)
Table 113. South America Cancer Ablation Devices Sales by Countries (2015-2020) (K Units)
Table 114. South America Cancer Ablation Devices Sales Market Share by Countries (2015-2020)
Table 115. South America Cancer Ablation Devices Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Cancer Ablation Devices Revenue Market Share by Countries (2015-2020)
Table 117. Middle East & Africa Cancer Ablation Devices Sales by Countries (2015-2020) (K Units)
Table 118. Middle East & Africa Cancer Ablation Devices Sales Market Share by Countries (2015-2020)
Table 119. Middle East & Africa Cancer Ablation Devices Revenue by Countries (2015-2020) (USD Million)
Table 120. Middle East & Africa Cancer Ablation Devices Revenue Market Share by Countries (2015-2020)
Table 121. Global Cancer Ablation Devices Sales by Type (2015-2020) (K Units)
Table 122. Global Cancer Ablation Devices Sales Share by Type (2015-2020)
Table 123. Global Cancer Ablation Devices Revenue by Type (2015-2020) (USD Million)
Table 124. Global Cancer Ablation Devices Revenue Share by Type (2015-2020)
Table 125. Global Cancer Ablation Devices Sales by Application (2015-2020) (K Units)
Table 126. Global Cancer Ablation Devices Sales Share by Application (2015-2020)
Table 127. Global Cancer Ablation Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 128. Global Cancer Ablation Devices Market Share Forecast by Regions (2021-2025)
Table 129. Global Cancer Ablation Devices Sales Forecast by Type (2021-2025) (K Units)
Table 130. Global Cancer Ablation Devices Market Share Forecast by Type (2021-2025)
Table 131. Global Cancer Ablation Devices Sales Forecast by Application (2021-2025)
Table 132. Global Cancer Ablation Devices Market Share Forecast by Application (2021-2025)
Table 133. Direct Channel Pros & Cons
Table 134. Indirect Channel Pros & Cons
Table 135. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cancer Ablation Devices Picture
Figure 2. Global Sales Market Share of Cancer Ablation Devices by Type in 2019
Figure 3. Cryoablation Picture
Figure 4. High-Intensity Focused Ultrasound (HIFU) Picture
Figure 5. Laser Interstitial Thermal Therapy (LiTT) Picture
Figure 6. Microwave Ablation (MWA) Picture
Figure 7. Radiofrequency Ablation (RFA) Picture
Figure 8. Irreversible Electroporation (Ire) Picture
Figure 9. Non-Thermal Ablation Picture
Figure 10. Cancer Ablation Devices Sales Market Share by Application in 2018
Figure 11. Brain Cancer Picture
Figure 12. Brown Picture
Figure 13. Colorectal Cancer Picture
Figure 14. Kidney Cancer Picture
Figure 15. Liver Cancer Picture
Figure 16. Lung Cancer Picture
Figure 17. Pancreatic Cancer Picture
Figure 18. Prostate Cancer Picture
Figure 19. Global Cancer Ablation Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 20. United States Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Canada Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Mexico Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Germany Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. France Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. UK Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Russia Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Italy Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. China Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Japan Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Korea Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 31. India Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Southeast Asia Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Australia Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 34. Brazil Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Egypt Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Saudi Arabia Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 37. South Africa Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 38. Turkey Cancer Ablation Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 39. Global Cancer Ablation Devices Sales Market Share by Manufacturer in 2019
Figure 40. Global Cancer Ablation Devices Revenue Market Share by Manufacturer in 2019
Figure 41. Top 3 Cancer Ablation Devices Manufacturer (Revenue) Market Share in 2019
Figure 42. Top 6 Cancer Ablation Devices Manufacturer (Revenue) Market Share in 2019
Figure 43. Key Manufacturer Market Share Trend
Figure 44. Global Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 45. Global Cancer Ablation Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. Global Cancer Ablation Devices Revenue Market Share by Regions (2015-2020)
Figure 47. Global Cancer Ablation Devices Revenue Market Share by Regions in 2018
Figure 48. North America Cancer Ablation Devices Sales and Growth Rate (2015-2020)
Figure 49. Europe Cancer Ablation Devices Sales and Growth Rate (2015-2020)
Figure 50. Asia-Pacific Cancer Ablation Devices Sales and Growth Rate (2015-2020)
Figure 51. South America Cancer Ablation Devices Sales and Growth Rate (2015-2020)
Figure 52. Middle East & Africa Cancer Ablation Devices Sales and Growth Rate (2015-2020)
Figure 53. North America Cancer Ablation Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. North America Cancer Ablation Devices Sales Market Share by Countries (2015-2020)
Figure 55. North America Cancer Ablation Devices Sales Market Share by Countries in 2018
Figure 56. North America Cancer Ablation Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 57. North America Cancer Ablation Devices Revenue Market Share by Countries in 2018
Figure 58. United States Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Canada Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Mexico Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Europe Cancer Ablation Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Europe Cancer Ablation Devices Revenue Market Share by Countries (2015-2020)
Figure 63. Europe Cancer Ablation Devices Revenue Market Share by Countries in 2019
Figure 64. Germany Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. UK Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. France Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Russia Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Italy Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Asia-Pacific Cancer Ablation Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. Asia-Pacific Cancer Ablation Devices Sales Market Share by Regions 2019
Figure 71. Asia-Pacific Cancer Ablation Devices Revenue Market Share by Regions 2019
Figure 72. China Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Japan Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Korea Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 75. India Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Southeast Asia Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 77. South America Cancer Ablation Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. South America Cancer Ablation Devices Sales Market Share by Countries in 2019
Figure 79. South America Cancer Ablation Devices Revenue Market Share by Countries in 2019
Figure 80. Brazil Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Argentina Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Middle East and Africa Cancer Ablation Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 83. Middle East and Africa Cancer Ablation Devices Sales Market Share by Countries in 2019
Figure 84. Middle East and Africa Cancer Ablation Devices Revenue Market Share by Countries (2015-2020)
Figure 85. Middle East and Africa Cancer Ablation Devices Revenue Market Share by Countries in 2019
Figure 86. Saudi Arabia Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Egypt Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 88. Turkey Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 89. South Africa Cancer Ablation Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 90. Global Cancer Ablation Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 91. Global Cancer Ablation Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 92. North America Sales Cancer Ablation Devices Market Forecast (2021-2025) (K Units)
Figure 93. Europe Sales Cancer Ablation Devices Market Forecast (2021-2025) (K Units)
Figure 94. Asia-Pacific Sales Cancer Ablation Devices Market Forecast (2021-2025) (K Units)
Figure 95. South America Sales Cancer Ablation Devices Market Forecast (2021-2025) (K Units)
Figure 96. Middle East & Africa Sales Cancer Ablation Devices Market Forecast (2021-2025) (K Units)
Figure 97. Sales Channel: Direct Channel vs Indirect Channel